| Authors: |
Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. Electronic address: cns9006@med.cornell.edu., Squifflet P; IDDI, Louvain-la-Neuve, Belgium., Saad ED; IDDI, Louvain-la-Neuve, Belgium., Burdett S; MRC Clinical Trials Unit at UCL, London, UK., Fisher D; MRC Clinical Trials Unit at UCL, London, UK., Kurt M; Bristol Myers Squibb, Princeton, NJ., Teitsson S; Bristol Myers Squibb, Uxbridge, UK., May JR; Bristol Myers Squibb, Uxbridge, UK., Patel MY; Bristol Myers Squibb, Princeton, NJ., Stoeckle M; Department of Urology, Saarland University Medical Center, Homburg, Germany., Torti F; Department of Medicine, University of Connecticut Health Center, Farmington, CT., Cote R; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO., Ruggeri EM; UOC Oncologia e Rete Oncologica, ASL, Viterbo, Italy., Zhegalik A; Urology, N. N. Alexandrov National Cancer Center, Lesnoy, Minsk District, Belarus., Tierney JF; MRC Clinical Trials Unit at UCL, London, UK., Collette L; IDDI, Louvain-la-Neuve, Belgium., Burzykowski T; IDDI, Louvain-la-Neuve, Belgium; Data Science Institute, Hasselt University, Diepenbeek, Belgium., Buyse M; IDDI, Louvain-la-Neuve, Belgium. |